文献速递头颈部肿瘤放疗

基于大队列预测头颈癌患者放射性黏膜炎

Prediction of radiation-induced mucositis of H&N cancer patients based on a large patient cohort.
PubMed 文献 · Radiother Oncol · 2020-03-28

研究基于802例连续头颈癌患者的前瞻性黏膜毒性评分,将毒性二分为非严重(0-2级)和严重(3+级)事件,利用DVH主成分分析结合LASSO和最佳子集选择构建预测模型,并在独立验证集中验证。两个模型验证集AUC分别为0.797(95%CI: 0.741-0.857)和0.808(95%CI: 0.749-0.859),内部Pearson系数0.954,显示稳健性。

要点

  • 治疗加速和口腔平均剂量及高低剂量平衡是严重黏膜炎的主要预测因素。
  • 两个模型验证集AUC均约0.8,内部相关性高,预测稳健。
  • 模型基于全剂量分布信息,可用于评估严重黏膜炎风险。

核心结论

  • 基于大型头颈癌队列的全剂量分布信息,成功开发了稳健的严重黏膜炎风险预测模型。

研究设计与样本

  • 前瞻性记录802例连续头颈癌患者的黏膜毒性评分,二分为非严重(0-2级)和严重(3+级)事件。
  • 使用LASSO和最佳子集选择结合10折交叉验证,在三分之二患者队列上进行DVH主成分分析建模,剩余三分之一用于验证。

主要发现

  • 主要预测风险因素为治疗加速和反映口腔平均剂量及高低剂量平衡的前两个主剂量成分。
  • LASSO模型还纳入性别和当前吸烟状态。
  • 两个模型验证集AUC分别为0.797(95%CI: 0.741-0.857)和0.808(95%CI: 0.749-0.859)。
  • 两个模型预测风险值内部Pearson系数为0.954,表明稳健性。

关键数值与推荐

  • 黏膜毒性二分为非严重事件(0-2级)和严重事件(3+级)。
  • 模型性能通过校准图和模型性能指标测试。

临床怎么用

  • 可利用治疗加速、口腔剂量分布等参数评估头颈癌患者严重黏膜炎风险。
  • 模型基于本机构五年内治疗患者数据,外部适用性需进一步验证。

局限性

  • 模型基于单中心五年内治疗患者数据,外部验证未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE/OBJECTIVE: Radiation-induced mucositis is a severe acute side effect, which can jeopardize treatment compliance and cause weight loss during treatment. The study aimed to develop robust models to predict the risk of severe mucositis. MATERIALS/METHODS: Mucosal toxicity scores were prospectively recorded for 802 consecutive Head and Neck (H&N) cancer patients and dichotomised into non-severe event (grade 0-2) and severe event (grade 3+) groups. Two different model approaches were utilised to evaluate the robustness of the models. These used LASSO and Best Subset selection combined with 10-fold cross-validation performed on two-thirds of the patient cohort using principal component analysis of DVHs. The remaining one-third of the patients were used for validation. Model performance was tested through calibration plot and model performance metrics. RESULTS: The main predicted risk factors were treatment acceleration and the first two principal dose components, which reflect the mean dose and the balance between high and low doses to the oral cavity. For the LASSO model, gender and current smoker status were also included in the model. The AUC values of the two models on the validation cohort were 0.797 (95%CI: 0.741-0.857) and 0.808 (95%CI: 0.749-0.859), respectively. The two models predicted very similar risk values with an internal Pearson coefficient of 0.954, indicating their robustness. CONCLUSIONS: Robust prediction models of the risk of severe mucositis have been developed based on information from the entire dose distribution for a large cohort of patients consisting of all patients treated H&N for within our institution over a five year period.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Hansen CR, Bertelsen A, Zukauskaite R, et al. Prediction of radiation-induced mucositis of H&N cancer patients based on a large patient cohort. Radiother Oncol. 2020. PMID: 32224314. doi:10.1016/j.radonc.2020.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。